vs
Asana, Inc.（ASAN）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是Asana, Inc.的1.1倍（$219.9M vs $201.0M），Orthofix Medical Inc.净利率更高（-1.0% vs -34.0%，领先33.0%），Asana, Inc.同比增速更快（9.3% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $15.5M），过去两年Asana, Inc.的营收复合增速更高（8.4% vs 8.0%）
Asana是一家总部位于美国旧金山的软件企业，由达斯汀·莫斯科维茨和贾斯汀·罗森斯坦于2008年创立，核心产品是同名工作管理平台，支持网页端与移动端使用，可帮助团队梳理、跟踪及统筹各类工作事项，2012年4月正式商业化推出，2020年9月直接上市，当时估值达55亿美元。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
ASAN vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$201.0M
营收增速更快
ASAN
高出7.4%
2.0%
净利率更高
OFIX
高出33.0%
-34.0%
自由现金流更多
OFIX
多$1.3M
$15.5M
两年增速更快
ASAN
近两年复合增速
8.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $201.0M | $219.9M |
| 净利润 | $-68.4M | $-2.2M |
| 毛利率 | 88.9% | 71.1% |
| 营业利润率 | -34.8% | 0.2% |
| 净利率 | -34.0% | -1.0% |
| 营收同比 | 9.3% | 2.0% |
| 净利润同比 | -19.4% | 92.4% |
| 每股收益（稀释后） | $-0.29 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASANOFIX
| Q4 25 | $201.0M | $219.9M | ||
| Q3 25 | $196.9M | $205.6M | ||
| Q2 25 | $187.3M | $203.1M | ||
| Q1 25 | $188.3M | $193.6M | ||
| Q4 24 | $183.9M | $215.7M | ||
| Q3 24 | $179.2M | $196.6M | ||
| Q2 24 | $172.4M | $198.6M | ||
| Q1 24 | $171.1M | $188.6M |
净利润ASANOFIX
| Q4 25 | $-68.4M | $-2.2M | ||
| Q3 25 | $-48.4M | $-22.8M | ||
| Q2 25 | $-40.0M | $-14.1M | ||
| Q1 25 | $-62.3M | $-53.1M | ||
| Q4 24 | $-57.3M | $-29.1M | ||
| Q3 24 | $-72.2M | $-27.4M | ||
| Q2 24 | $-63.7M | $-33.4M | ||
| Q1 24 | $-62.4M | $-36.0M |
毛利率ASANOFIX
| Q4 25 | 88.9% | 71.1% | ||
| Q3 25 | 89.7% | 72.2% | ||
| Q2 25 | 89.7% | 68.7% | ||
| Q1 25 | 89.6% | 62.8% | ||
| Q4 24 | 89.2% | 69.0% | ||
| Q3 24 | 88.8% | 68.7% | ||
| Q2 24 | 89.7% | 67.8% | ||
| Q1 24 | 89.8% | 67.5% |
营业利润率ASANOFIX
| Q4 25 | -34.8% | 0.2% | ||
| Q3 25 | -25.1% | -8.3% | ||
| Q2 25 | -23.4% | -7.9% | ||
| Q1 25 | -33.8% | -25.2% | ||
| Q4 24 | -32.7% | -5.3% | ||
| Q3 24 | -42.9% | -9.6% | ||
| Q2 24 | -38.4% | -12.5% | ||
| Q1 24 | -39.7% | -15.6% |
净利率ASANOFIX
| Q4 25 | -34.0% | -1.0% | ||
| Q3 25 | -24.6% | -11.1% | ||
| Q2 25 | -21.4% | -6.9% | ||
| Q1 25 | -33.1% | -27.4% | ||
| Q4 24 | -31.2% | -13.5% | ||
| Q3 24 | -40.3% | -13.9% | ||
| Q2 24 | -37.0% | -16.8% | ||
| Q1 24 | -36.5% | -19.1% |
每股收益（稀释后）ASANOFIX
| Q4 25 | $-0.29 | $-0.05 | ||
| Q3 25 | $-0.20 | $-0.57 | ||
| Q2 25 | $-0.17 | $-0.36 | ||
| Q1 25 | $-0.27 | $-1.35 | ||
| Q4 24 | $-0.25 | $-0.76 | ||
| Q3 24 | $-0.31 | $-0.71 | ||
| Q2 24 | $-0.28 | $-0.88 | ||
| Q1 24 | $-0.28 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $183.5M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $188.4M | $450.0M |
| 总资产 | $840.4M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASANOFIX
| Q4 25 | $183.5M | $82.0M | ||
| Q3 25 | $184.1M | $62.9M | ||
| Q2 25 | $193.8M | $65.6M | ||
| Q1 25 | $184.7M | $58.0M | ||
| Q4 24 | $196.8M | $83.2M | ||
| Q3 24 | $219.4M | $30.1M | ||
| Q2 24 | $222.0M | $26.4M | ||
| Q1 24 | $236.7M | $27.0M |
总债务ASANOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益ASANOFIX
| Q4 25 | $188.4M | $450.0M | ||
| Q3 25 | $224.6M | $442.5M | ||
| Q2 25 | $236.3M | $458.3M | ||
| Q1 25 | $227.5M | $458.3M | ||
| Q4 24 | $239.3M | $503.1M | ||
| Q3 24 | $291.9M | $525.9M | ||
| Q2 24 | $319.9M | $546.0M | ||
| Q1 24 | $326.4M | $570.3M |
总资产ASANOFIX
| Q4 25 | $840.4M | $850.6M | ||
| Q3 25 | $883.2M | $832.6M | ||
| Q2 25 | $877.1M | $837.2M | ||
| Q1 25 | $891.4M | $823.1M | ||
| Q4 24 | $874.2M | $893.3M | ||
| Q3 24 | $945.4M | $867.9M | ||
| Q2 24 | $978.2M | $882.0M | ||
| Q1 24 | $962.0M | $906.0M |
负债/权益比ASANOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.2M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $15.5M | $16.8M |
| 自由现金流率自由现金流/营收 | 7.7% | 7.6% |
| 资本支出强度资本支出/营收 | 0.3% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $74.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流ASANOFIX
| Q4 25 | $16.2M | $27.7M | ||
| Q3 25 | $39.8M | $12.4M | ||
| Q2 25 | $6.8M | $11.6M | ||
| Q1 25 | $15.9M | $-18.4M | ||
| Q4 24 | $-14.9M | $23.7M | ||
| Q3 24 | $15.9M | $11.7M | ||
| Q2 24 | $-1.9M | $9.0M | ||
| Q1 24 | $-15.3M | $-18.6M |
自由现金流ASANOFIX
| Q4 25 | $15.5M | $16.8M | ||
| Q3 25 | $38.5M | $2.5M | ||
| Q2 25 | $6.1M | $4.5M | ||
| Q1 25 | $14.3M | $-25.1M | ||
| Q4 24 | $-16.3M | $15.2M | ||
| Q3 24 | $14.2M | $6.3M | ||
| Q2 24 | $-2.9M | $-360.0K | ||
| Q1 24 | $-15.8M | $-29.1M |
自由现金流率ASANOFIX
| Q4 25 | 7.7% | 7.6% | ||
| Q3 25 | 19.6% | 1.2% | ||
| Q2 25 | 3.3% | 2.2% | ||
| Q1 25 | 7.6% | -13.0% | ||
| Q4 24 | -8.8% | 7.0% | ||
| Q3 24 | 7.9% | 3.2% | ||
| Q2 24 | -1.7% | -0.2% | ||
| Q1 24 | -9.3% | -15.4% |
资本支出强度ASANOFIX
| Q4 25 | 0.3% | 4.9% | ||
| Q3 25 | 0.7% | 4.8% | ||
| Q2 25 | 0.3% | 3.5% | ||
| Q1 25 | 0.8% | 3.5% | ||
| Q4 24 | 0.7% | 4.0% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 0.6% | 4.7% | ||
| Q1 24 | 0.3% | 5.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASAN
| US | $118.5M | 59% |
| Non Us | $82.5M | 41% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
